Loading...
The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood
BACKGROUND AND PURPOSE: Stimulation of soluble guanylyl cyclase (sGC) is a valuable therapeutic strategy for the treatment of several cardiovascular diseases. The sGC stimulator riociguat has been approved for the treatment of two forms of pulmonary hypertension. Platelets contain large amounts of s...
Na minha lista:
| Udgivet i: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687809/ https://ncbi.nlm.nih.gov/pubmed/26282717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13286 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|